FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023900607> ?p ?o ?g. }

• W2023900607 endingPage "56" @default.
• W2023900607 startingPage "44" @default.
• W2023900607 abstract "Targeting higher hemoglobin levels with erythropoiesis-stimulating agents (ESAs) to treat the anemia of chronic kidney disease (CKD) is associated with increased cardiovascular risk.Metaregression analysis examining the association of ESA dose with adverse outcomes independent of target or achieved hemoglobin level.Patients with anemia of CKD irrespective of dialysis status.We searched MEDLINE (inception to August 2010) and bibliographies of published meta-analyses and selected randomized controlled trials assessing the efficacy of ESAs for the treatment of anemia in adults with CKD, with a minimum 3-month duration. Two authors independently screened citations and extracted relevant data. Individual study arms were treated as cohorts and constituted the unit of analysis.ESA dose standardized to a weekly epoetin alfa equivalent, and hemoglobin levels.All-cause and cardiovascular mortality, cardiovascular events, kidney disease progression, or transfusion requirement.31 trials (12,956 patients) met the criteria. All-cause mortality was associated with higher (per epoetin alfa-equivalent 10,000-U/wk increment) first-3-month mean ESA dose (incidence rate ratio [IRR], 1.42; 95% CI, 1.10-1.83) and higher total-study-period mean ESA dose (IRR, 1.09; 95% CI, 1.02-1.18). First-3-month ESA dose remained significant after adjusting for first-3-month mean hemoglobin level (IRR, 1.48; 95% CI, 1.02-2.14), as did total-study-period mean ESA dose adjusting for target hemoglobin level (IRR, 1.41; 95% CI, 1.08-1.82). Parameter estimates between ESA dose and cardiovascular mortality were similar in magnitude and direction, but not statistically significant. Higher total-study-period mean ESA dose also was associated with increased rate of hypertension, stroke, and thrombotic events, including dialysis vascular access-related thrombotic events.Use of study-level aggregated data; use of epoetin alfa-equivalent doses; lack of adjustment for confounders.In patients with CKD, higher ESA dose might be associated with all-cause mortality and cardiovascular complications independent of hemoglobin level." @default.
• W2023900607 created "2016-06-24" @default.
• W2023900607 creator A5000950219 @default.
• W2023900607 creator A5035622739 @default.
• W2023900607 creator A5062268434 @default.
• W2023900607 creator A5074694483 @default.
• W2023900607 creator A5075294963 @default.
• W2023900607 date "2013-01-01" @default.
• W2023900607 modified "2023-10-10" @default.
• W2023900607 title "Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis" @default.
• W2023900607 cites W137395437 @default.
• W2023900607 cites W1537972189 @default.
• W2023900607 cites W1963948824 @default.
• W2023900607 cites W1967972391 @default.
• W2023900607 cites W1977623079 @default.
• W2023900607 cites W1983659087 @default.
• W2023900607 cites W1986215651 @default.
• W2023900607 cites W1989268721 @default.
• W2023900607 cites W1998943227 @default.
• W2023900607 cites W2001920176 @default.
• W2023900607 cites W2005973637 @default.
• W2023900607 cites W2023146075 @default.
• W2023900607 cites W2033601942 @default.
• W2023900607 cites W2033803279 @default.
• W2023900607 cites W2036756589 @default.
• W2023900607 cites W2040029744 @default.
• W2023900607 cites W2040421189 @default.
• W2023900607 cites W2046224330 @default.
• W2023900607 cites W2046615795 @default.
• W2023900607 cites W2049032499 @default.
• W2023900607 cites W2049666202 @default.
• W2023900607 cites W2052420613 @default.
• W2023900607 cites W2055785689 @default.
• W2023900607 cites W2086342871 @default.
• W2023900607 cites W2086599987 @default.
• W2023900607 cites W2088085043 @default.
• W2023900607 cites W2088293785 @default.
• W2023900607 cites W2094875169 @default.
• W2023900607 cites W2103320383 @default.
• W2023900607 cites W2103517401 @default.
• W2023900607 cites W2109081740 @default.
• W2023900607 cites W2112671041 @default.
• W2023900607 cites W2115208217 @default.
• W2023900607 cites W2115593565 @default.
• W2023900607 cites W2120612796 @default.
• W2023900607 cites W2120939456 @default.
• W2023900607 cites W2134487085 @default.
• W2023900607 cites W2139537558 @default.
• W2023900607 cites W2140188175 @default.
• W2023900607 cites W2140623175 @default.
• W2023900607 cites W2141767690 @default.
• W2023900607 cites W2142926804 @default.
• W2023900607 cites W2148520689 @default.
• W2023900607 cites W2152075897 @default.
• W2023900607 cites W2152157740 @default.
• W2023900607 cites W2159986663 @default.
• W2023900607 cites W2160581087 @default.
• W2023900607 cites W2161040354 @default.
• W2023900607 cites W2164879524 @default.
• W2023900607 cites W2166090054 @default.
• W2023900607 cites W2230081873 @default.
• W2023900607 cites W2321111200 @default.
• W2023900607 cites W2343604581 @default.
• W2023900607 cites W4213306416 @default.
• W2023900607 cites W4232386529 @default.
• W2023900607 cites W4239560882 @default.
• W2023900607 cites W3149132779 @default.
• W2023900607 doi "https://doi.org/10.1053/j.ajkd.2012.07.014" @default.
• W2023900607 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3525813" @default.
• W2023900607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22921639" @default.
• W2023900607 hasPublicationYear "2013" @default.
• W2023900607 type Work @default.
• W2023900607 sameAs 2023900607 @default.
• W2023900607 citedByCount "155" @default.
• W2023900607 countsByYear W20239006072013 @default.
• W2023900607 countsByYear W20239006072014 @default.
• W2023900607 countsByYear W20239006072015 @default.
• W2023900607 countsByYear W20239006072016 @default.
• W2023900607 countsByYear W20239006072017 @default.
• W2023900607 countsByYear W20239006072018 @default.
• W2023900607 countsByYear W20239006072019 @default.
• W2023900607 countsByYear W20239006072020 @default.
• W2023900607 countsByYear W20239006072021 @default.
• W2023900607 countsByYear W20239006072022 @default.
• W2023900607 countsByYear W20239006072023 @default.
• W2023900607 crossrefType "journal-article" @default.
• W2023900607 hasAuthorship W2023900607A5000950219 @default.
• W2023900607 hasAuthorship W2023900607A5035622739 @default.
• W2023900607 hasAuthorship W2023900607A5062268434 @default.
• W2023900607 hasAuthorship W2023900607A5074694483 @default.
• W2023900607 hasAuthorship W2023900607A5075294963 @default.
• W2023900607 hasBestOaLocation W20239006072 @default.
• W2023900607 hasConcept C120665830 @default.
• W2023900607 hasConcept C121332964 @default.
• W2023900607 hasConcept C126322002 @default.
• W2023900607 hasConcept C167704817 @default.
• W2023900607 hasConcept C197934379 @default.
• W2023900607 hasConcept C2776164570 @default.

• next